Jose Manuel Valdivielso Revilla
Grado: Doctor/a
973 702 952
valdivielso(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/B-5673-2009
Publicaciones
-
Palanca, A; Castelblanco, E; Betriu À; Perpiñán H; Soldevila, B; Valdivielso, JM; Bermudez-Lopez, M; Puig-Jove, C; Puig-Domingo, M; Groop, PH; Fernandez, E; Alonso, N; Mauricio, D
Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
Cardiovascular Diabetology 18 93-93. .
-
Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Expert Opinion On Therapeutic Targets 23 619-630. .
-
Bozic, M; Caus, M; Rodrigues-Diez, RR; Ruiz-Ortega, M; Martinez, A; Blasco, A; Gallel, P; Fernandez, E; Valdivielso, JM
ALPHA-SYNUCLEIN MAINTAINS THE EPITHELIAL PHENOTYPE AND PROTECTS FROM RENAL FIBROSIS
NEPHROLOGY DIALYSIS TRANSPLANTATION 34 156-156. .
-
Caus, M; Bozic, M; Fernandez, E; Valdivielso, JM
ABSENCE OF VDR SOLELY IN VSMCS IMPEDES ARTERIAL CALCIFICATION IN CKD THROUGH TARGETING MIR-145A AND MIR-155
NEPHROLOGY DIALYSIS TRANSPLANTATION 34 190-190. .
-
Cambray, S; Galimudi, RK; Bozic, M; Bermudez-Lopez, M; Rodriguez, I; Valdivielso, JM
A The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort
Journal of Clinical Medicine 8 -. .
-
Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project
Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project
Journal of Atherosclerosis and Thrombosis 26 879-889. .
-
Valls J; Cambray S; Pérez-Guallar C; Bozic M; Bermúdez-López M; Fernández E; Betriu À; Rodríguez I; Valdivielso JM
Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort
Frontiers in Genetics 10 118-118. .
-
Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C
Lipid management in patients with chronic kidney disease (vol 14, pg 727, 2018)
NATURE REVIEWS NEPHROLOGY 15 121-121. .
-
Sarafidis, P; Ferro, CJ; Morales, E; Ortiz, A; Malyszko, J; Hojs, R; Khazim, K; Ekart, R; Valdivielso, J; Fouque, D; London, GM; Massy, Z; Ruggenenti, P; Porrini, E; Wiecek, A; Zoccali, C; Mallamaci, F; Hornum, M
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
NEPHROLOGY DIALYSIS TRANSPLANTATION 34 208-230. .
-
Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M; CKD Prognosis Consortium (CKD-PC)
Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
BMJ-BRITISH MEDICAL JOURNAL 364 -. .
-
Valdivielso, JM; Jacobs-Cacha, C; Soler, MJ
Sex hormones and their influence on chronic kidney disease
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 28 1-9. .
-
Perez-Morales, RE; del Pino, M; Valdivielso, JM; Ortiz, A; Mora-Fernandez, C; Navarro-Gonzalez, JF
Inflammation in Diabetic Kidney Disease
Nephron 143 12-16. .
Proyectos
- Calprotectin as a new companion biomarker and associated drug target for premature vascular aging in chronic kidney disease and type 2 diabetes
- Estancias de personal docente y/o investigador senior en centros extranjeros 2022
- El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
- Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
- SPAIN CKD CAUSE (SPACKDC)
- INVESTIGO 2022: Grup de recerca translacional vascular i renal
- Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
- Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
- Acciones de Dinamización "Europa Investigación 2020"
- Contratos Sara Borrell
- Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
- Ajuts destinats a contractar personal investigador novell (FI)